Yale Neurologist Dr. Lauren Sansing Awarded 2024 Basic Research Prize for Stroke Recovery Studies
TL;DR
Dr. Sansing's research will change the landscape of stroke treatment, providing an advantage in understanding and improving recovery potential.
Dr. Sansing's lab studies immune system responses after stroke and aims to apply knowledge to patient care for better recovery.
Dr. Sansing's work will improve outcomes after stroke, maximizing recovery potential and changing the landscape of stroke treatment for a better tomorrow.
Dr. Sansing, a professor at Yale School of Medicine, focuses on maximizing recovery potential for people who experience neurovascular diseases like stroke.
Found this article helpful?
Share it with your network and spread the knowledge!
The American Heart Association (AHA) has announced that Dr. Lauren H. Sansing, professor of neurology at Yale School of Medicine, will be awarded the prestigious Basic Research Prize during the AHA's Scientific Sessions 2024 in Chicago. This recognition highlights Dr. Sansing's significant contributions to understanding and improving outcomes for patients with complex neurovascular diseases, particularly stroke and intracerebral hemorrhage.
Dr. Sansing's research focuses on the immune system's role in brain recovery after stroke and other cerebrovascular injuries. Her work aims to differentiate between beneficial and harmful immune responses, with the ultimate goal of enhancing healing processes and suppressing those that impede recovery. This approach could lead to more effective treatments and improved outcomes for stroke patients.
The importance of Dr. Sansing's research lies in its potential to transform stroke treatment. As stroke remains a leading cause of death and disability worldwide, advancements in recovery methods could have far-reaching implications for public health. Dr. Keith Churchwell, AHA's 2024-2025 volunteer president, emphasized that Dr. Sansing's discoveries may soon change the landscape of stroke treatment.
At Yale, Dr. Sansing leads a team of 14 researchers studying immune responses in various neurovascular conditions. Her lab's work extends beyond basic research to include rigorous testing of potential stroke treatments through the NINDS-funded Stroke Preclinical Assessment Network. This translational approach bridges the gap between laboratory findings and clinical applications, accelerating the development of new therapies.
Dr. Sansing's impact extends beyond her research. She is actively involved in mentoring future scientists and physician-scientists, directing educational programs at Yale School of Medicine, and participating in multiple clinical trials. Her commitment to both research and education ensures that her work will influence the field of neurology for years to come.
The recognition of Dr. Sansing's work by the AHA underscores the critical importance of basic research in advancing medical treatments. As stroke remains a significant health concern, innovative approaches like those developed by Dr. Sansing and her team offer hope for improved patient outcomes and reduced societal burden of cerebrovascular diseases.
Curated from NewMediaWire
